Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(171 intermediate revisions by 6 users not shown)
Line 1: Line 1:


{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Myeloproliferative Neoplasms (MPN)||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|
|
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|
|
|complete
|
|FQR
|
|
|-
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|-
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|
|
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|(trainee), Daynna J.Wolff
|
|
|pending faculty review
|
|FQR
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|
|
|
|
|-
|-
|Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
| ||FQR
|
|
|
|
|-
|-
|Chronic Neutrophilic Leukemia (CNL)||Disease
|    Cutaneous  Mastocytosis||Disease
| ||FQR
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|
|
|-
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|
|
|complete
|
|FQR
|
|
|-
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|
|
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|FQR
|
|
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|9/1/20
|pending
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|FQR
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Complete
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|Complete
|02/03/2021||JH / MS
|
|
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|Complete
|
|JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|Add WHO reference
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Polycythaemia Vera (PV)||Disease
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Primary Myelofibrosis (PMF)||Disease
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Essential Thrombocythaemia (ET)||Disease
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Mastocytosis||'''''Overview'''''|| ||FQR
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Cutaneous Mastocytosis||Disease
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Systemic Mastocytosis||Disease
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Mast Cell Sarcoma||Disease
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2||'''''Overview'''''|| ||FQR
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|-
|-
|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)||'''''Overview'''''|| ||FQR
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|Chronic Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic Syndromes (MDS)||'''''Overview'''''|| ||FQR
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage  Dysplasia||Disease|| ||FQR
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|PENDING
|
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic syndrome with multilineage  dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease|| ||FQR
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS), Unclassifiable||Disease|| ||FQR
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Refractory Cytopenia of Childhood||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|YA
|
|
|
|
|-
|-
| || || ||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms||'''''Overview'''''|| ||Jennelle Hodge (JH)
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline Predisposition||'''''Overview'''''|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline DDX41 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline RUNX1 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline ETV6 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms  with Germline GATA2 Mutation||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities||'''''Overview'''''|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Promyelocytic  Leukemia (APL) with PML-RARA||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with BCR-ABL1||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Mutated NPM1||Disease|| ||JH
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Biallelic Mutations of CEBPA||Disease|| ||JH
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease|| ||JH
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease|| ||JH
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease|| ||JH
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML), Not Otherwise Specified||'''''Overview'''''|| ||JH
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) without Maturation||Disease|| ||JH
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Maturation||Disease|| ||JH
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute  Myelomonocytic Leukemia||Disease|| ||JH
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Pure Erythroid Leukemia||Disease|| ||JH
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Mu Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|           Primary  Amyloidosis||Disease||
|
|
|
| ||SP
|
|
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute  Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute Basophilic  Leukemia||Disease|| ||JH
|         POEMS Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute Panmyelosis  with Myelofibrosis||Disease|| ||JH
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease|| ||JH
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Myeloid Proliferations Associated with Down Syndrome||'''''Overview'''''|| ||JH
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease|| ||JH
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|Myeloid Leukemia  Associated with Down Syndrome||Disease|| ||JH
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Acute Leukemias of Ambiguous Lineage||'''''Overview'''''|| ||JH
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Acute Undifferentiated Leukemia||Disease|| ||JH
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease|| ||JH
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|??Acute Leukaemias  of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
| || || ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Example||Example|| ||Example
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Multicentric Castleman  Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Example||Example|| ||Example
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Aggressive NK-cell Leukemia||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphomatoid  Papulosis||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Example||Example|| ||Example
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MLTT3
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|KMT2A
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RBM15
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MKL1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ANKRD26
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CUX1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|TET2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EZH2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FOXP1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MYC
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|JAK2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|WT1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CBL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NF1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SUZ12
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ERG
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EST2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RPS14
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RB1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MPL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CHGA
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CDH1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SRSF2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DNMT1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PRDX2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MN1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SF3A1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EP300
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|JARID2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|BRCA1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|BRCA2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|
|
|
|
|
|
|
|
|
|
|
|}
|}

Revision as of 12:28, 28 May 2021

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera complete Fabiola Quintero-Rivera (FQR)
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera complete FQR
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR
    Polycythaemia Vera (PV) Disease Gokce A. Toruner complete FQR
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne complete FQR 8/4/2020 before submission
    Essential Thrombocythaemia (ET) Disease Rebecca Smith (trainee) + Fabiola Quintero-Rivera complete/pending faculty review FQR
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease (trainee), Daynna J.Wolff pending faculty review FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Thomas Lee 8/17/2020 9/7/2020 complete FQR
Mastocytosis Overview Shashi Shetty, Ph.D. complete FQR
    Cutaneous Mastocytosis Disease Thuy Phung/Shuo-Shawn Liu complete/pending adding content online as of 2/4/21 FQR
    Systemic Mastocytosis Disease Shashi Shetty complete FQR
    Mast Cell Sarcoma Disease Thuy Phung +Jordan Lowery complete FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding Complete FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff Complete FQR
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang Complete FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang Complete FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang Complete FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo 9/1/20 PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon complete FQR
Myelodysplastic Syndromes (MDS) Overview Teresa Smolarek? 9/1/20 pending FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek complete FQR
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Complete Jennelle Hodge (JH)/ Malini Sathanoori (MS) 04/26/2021 -MS (re-review)
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) PENDING JH / MS 04/26/2021 -MS (re-review)
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang Complete JH / MS 03/01/2021-MS
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori Complete 02/03/2021 JH / MS
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang Complete JH / MS 03/02/2021-MS
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou Complete JH / MS 03/02/2021-MS (re-review)
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) Complete JH / MS 04/26/2021 -MS (re-review)
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke Complete JH / MS 04/26/2021-MS (re-review)
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke Complete JH / MS 03/01/2021-MS (re-review)
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge Complete JH / MS 02/24/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca Complete JH / MS Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang Complete JH / MS
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) Complete JH / MS Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal Complete JH / MS
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) Complete JH / MS
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myelomonocytic Leukemia Disease Fei Yang Complete JH / MS
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang Complete JH / MS
    Pure Erythroid Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang Complete JH / MS
    Acute Basophilic Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) Complete JH / MS
Myeloid Sarcoma Disease Fabiola Quintero-Rivera Complete JH / MS
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp Complete JH / MS Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) Complete JH / MS
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge Complete JH / MS
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera Complete JH / MS
    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types Disease Daynna Wolff+ Elicia Goodale (resident) PENDING JH / MS
    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease Daynna Wolff+Madison Hannay or Elicia Goodale (residents) PENDING JH / MS
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) PENDING JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) PENDING JH / MS NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease Afia Hasnain + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease Marilena Melas + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease Afia Hasnain + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease Holli Drendel PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease Holli Drendel PENDING YA
B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 Disease Diana Rush PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Marilena Melas PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions Disease Chenkai Ma PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) Disease Alaa Koleilat PENDING YA NON-WHO ENTITY
T-Lymphoblastic Leukemia/Lymphoma Overview Fei Yang PENDING YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease Fei Yang PENDING YA
NK-Lymphoblastic Leukemia/Lymphoma Disease Fei Yang PENDING YA
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease SP
       Monoclonal B-cell Lymphocytosis Disease SP
B-cell Prolymphocytic Leukemia Disease SP
Splenic Marginal Zone Lymphoma Disease Snehal Patel Complete SP
Hairy Cell Leukemia Disease Snehal Patel Complete SP
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel Complete SP
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel Complete SP
    Hairy Cell Leukemia Variant Disease Snehal Patel Complete SP
Lymphoplasmacytic Lymphoma Disease SP
   Waldenstrom Macroglobulinemia Disease SP
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease Manisha Sutariya Complete 5/26/2021 SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang PENDING SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang PENDING SP
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) PENDING SP
    Plasma Cell Myeloma Variants Disease Fariborz Rashid-Kolvear PENDING SP
    Plasmacytoma Disease Zhenya Tang PENDING SP
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Whayoung Lee, trainee)/Fabiola Quintero-Rivera 3/9/21 PENDING SP
Nodal Marginal Zone Lymphoma Disease Shivani Golem Complete 5/28/2021 SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 11/11/2020 SP
Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    Testicular Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    In Situ Follicular Neoplasia Disease Ruthann Pfau PENDING SP
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau PENDING SP
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 8/16/2020 SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease Afia Hasnaid 9/30/20 Complete 5/26/2021 SP
Primary Cutaneous Follicle Centre Lymphoma Disease Shivani Golem PENDING SP
Mantle Cell Lymphoma Disease Mahsa Khanlari 8/15/20 PENDING SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease SP
    In Situ Mantle Cell Neoplasia Disease SP
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra PENDING Greg Corboy (GC)
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera Complete GC
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease Becky Leung (trainee), Greg Corboy 3/11/21 PENDING GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don PENDING SP
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don PENDING SP
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don PENDING SP
Aggressive NK-cell Leukemia Disease SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease Lisa Lansdon (trainee) PENDING SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) Complete 1/21/2021 SP
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara PENDING SP
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
Hepatosplenic T-cell Lymphoma Disease Michelle Don Complete 1/21/2021 SP
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease Daynna Wolff, Jane Scribner (trainee) PENDING SP
Sézary Syndrome Disease Daynna Wolff, Madison Hannay (trainee) PENDING SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview SP
    Lymphomatoid Papulosis Disease SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease Hans Hamnvåg PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara PENDING SP
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara PENDING SP
Hodgkin Lymphomas Overview Greg Corboy (GC)
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease GC
Classic Hodgkin Lymphoma Overview GC
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease GC
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease GC
    Mixed Cellularity Classic Hodgkin Lymphoma Disease GC
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease GC
Immunodeficiency-Associated Lymphoproliferative Disorders Overview GC
Lymphomas Associated with HIV Infection Disease GC
Post-Transplant Lymphoproliferative Disorders Overview GC
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease GC
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Anna Shestakova (trainee)+,

Fabiola Quintero-Rivera

PENDING GC
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview GC
          Monomorphic B-cell PTLD Disease GC
          Monomorphic T/NK-cell PTLD Disease GC
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease GC
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease GC
Histiocytic and Dendritic Cell Neoplasms Overview GC
Histiocytic Sarcoma Disease GC
Tumors Derived From Langerhans Cells Overview GC
   Langerhans Cell Histiocytosis Disease GC
   Langerhans Cell Sarcoma Disease GC
Indeterminate Dendritic Cell Tumour Disease GC
Interdigitating Dendritic Cell Sarcoma Disease GC
Follicular Dendritic Cell Sarcoma Disease GC
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease GC
Fibroblastic Reticular Cell Tumor Disease GC
Disseminated Juvenile Xanthogranuloma Disease GC
Erdheim-Chester Disease Disease GC
Gene-Specific Pages
Gene Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BCR Brian Davis Complete 8/10/18
ABL1 Brian Davis Complete 4/16/19
RUNX1 Brian Davis Complete 6/9/19
RUNX1T1 Brian Davis Complete 5/23/19
MYH11 Brian Davis Complete 8/6/18
FLT3 Kay Weng Choy Complete
NPM1 Kay Weng Choy Complete
TP53 Kay Weng Choy Complete
DNMT3A Kay Weng Choy Complete
CEBPA Gordana Complete
IDH1 Paul De Fazio Complete
IDH2 Paul De Fazio Complete
PML Brian Davis Complete 12/5/18
RARA Brian Davis Complete 8/3/18
ETV6 Brian Davis Complete 6/9/19
KIT Brian Davis Complete 10/1/18
CBFB Brian Davis Complete 8/2/18
GATA2 Kay Weng Choy Complete
PTEN Beth Pitel Pending
MLTT3
MECOM Brian Davis Pending
FGFR1(FLT2) Brian Davis Pending
KMT2A
DEK Wahab A. Khan Pending
NUP214 Wahab A. Khan Pending
RBM15
MKL1
DDX41 Ying Zou 8/7/20 Pending
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1 DONE DONE
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1 DONE DONE
MN1
SF3A1
EP300
JARID2
BRCA1
BRCA2
Retrieved from "https://content.ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=10289"